Oxyrane UK Company

Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.

Industry: PharmTech
Funding Status: Late Stage Venture
Last Funding Type: Series D
Employee Number: 11-50
Headquarters: Manchester, Manchester, United Kingdom
Investors Number: 3
Founded Date: 2007
Total Funding: £16 721 500
Estimated Revenue: £7 800 000-38 990 000
Last Funding Date: 11-17-2011